Bruce Melancon

Bruce Melancon, Ph.D. is a Senior Director of Medicinal Chemistry at the Warren Center for Neuroscience Drug Discovery. Bruce also holds the position of Editor In Chief for ASSAY and Drug Development Technologies at Mary Ann Liebert, Inc. Bruce has a background in chemistry, with experience in pharmaceutical research, structure-activity relationship studies, and chemical synthesis. Bruce holds a Ph.D. in Chemistry from the University of Notre Dame.